Saturday, August 1, 2020

Zydus Cadila gets tentative nod from USFDA to market Parkinson's disease drug

The company has received tentative approval from the United States
Food and Drug Administration (USFDA) to market the capsules in the
strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and
61.25 mg/245 mg, Zydus Cadila said in a statement.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-tentative-nod-from-usfda-to-market-parkinsons-disease-drug/articleshow/77299625.cms

No comments:

Post a Comment